This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect of VC005 Tablets in healthy subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
31
Oral administration after fasting/high-fat meal
Oral administration after fasting/high-fat meal
Zhongda Hospital,Affiliated to Southeast
Nanjing, Jiangsu, China
Maximum Observed Plasma Concentration (Cmax)
Time frame: Day1-Day7
Area under the plasma concentration-time curve(AUC)
Time frame: Day1-Day7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.